Clinical Trial

Abnormal Connectivity Involving the Social Reciprocity Network in Autism and the Impact of Neurostimulation in Mitigating the Abnormalities

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 21, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
There is no consensus regarding the neurological substrate underpinning ASD. The investigators describe the novel concept of "social reciprocity network" and hypothesize that aberrant connectivity/oscillatory patterns affecting this network contribute to the core deficits in ASD. The overarching goal of this trial is to explore abnormalities involving the neuronal connectivity and oscillatory patterns within the social reciprocity network and to elucidate the role of modulating this network via rTMS in improving the above measures and social cognition in ASD. Quantitative electroencephalography (QEEG) coherence and spectral power analysis are reliable measures of neuronal connectivity and dynamics. The investigators aim to study the QEEG coherence/spectral power analysis to explore the neuronal dynamics affecting the social reciprocity network in ASD.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-01-29; most recent amendment 2026-06-16.
Status change: Recruiting → Completed 2026-05-01
Trial Details
NCT Number NCT06807684
Lead Sponsor Christiana Care Health Services
Conditions Autism Spectrum Disorder
Enrollment 12 participants
Start Date 2024-08-15
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-21